Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATNM

Actinium Pharmaceuticals Inc

May 13 • 04:00PM ET

1.29

-0.01 -0.77 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: CUE SLS CLRB CVM BLRX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	3.12%	Shs Outstand	31.37M	Perf Week	4.03%
Market Cap	40.48M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	30.40M	Perf Month	17.27%
Enterprise Value	-0.13M	PEG	-	EPS next Q	-0.21	Inst Own	19.78%	Short Float	3.49%	Perf Quarter	15.18%
Income	-23.47M	P/S	449.74	EPS this Y	24.08%	Inst Trans	0.71%	Short Ratio	5.88	Perf Half Y	-3.01%
Sales	0.09M	P/B	17.57	EPS next Y	4.13%	ROA	-41.15%	Short Interest	1.06M	Perf YTD	-5.15%
Book/sh	0.07	P/C	0.96	EPS next 5Y	23.57%	ROE	-167.66%	52W High	1.95 -33.69%	Perf Year	-15.13%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-759.83%	52W Low	0.95 35.51%	Perf 3Y	-84.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-828.89%	Volatility	5.40% 7.90%	Perf 5Y	-81.60%
Dividend TTM	-	EV/Sales	-1.49	EPS Y/Y TTM	48.96%	Oper. Margin	-28346.67%	ATR (14)	0.08	Perf 10Y	-97.60%
Dividend Ex-Date	-	Quick Ratio	5.89	Sales Y/Y TTM	11.11%	Profit Margin	-26078.89%	RSI (14)	54.95	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.89	EPS Q/Q	65.39%	SMA20	1.30%	Beta	-0.08	Target Price	5.75
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	9.50%	Rel Volume	0.43	Prev Close	1.30
Employees	25	LT Debt/Eq	0.34	Earnings	Mar 13	SMA200	-6.64%	Avg Volume	180.18K	Price	1.29
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.77% -	Trades		Volume	76,716	Change	-0.77%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)